The market for anti-obesity drugs could hit $100 billion

By 2030, the global market for anti-obesity medications could grow by more than 16 times to $100 billion, up from $6 billion annualized sales this year, according to Goldman Sachs Research. Our analysts estimate the weight management market could yield some of the highest-grossing drugs of all time.  These new-generation therapies are emerging as obesity rates continue

The market for anti-obesity drugs could hit $100 billion Read More »

Scroll to Top